PE20030340A1 - Metodo para el tratamiento o prevencion de desgaste oseo - Google Patents
Metodo para el tratamiento o prevencion de desgaste oseoInfo
- Publication number
- PE20030340A1 PE20030340A1 PE2002000815A PE2002000815A PE20030340A1 PE 20030340 A1 PE20030340 A1 PE 20030340A1 PE 2002000815 A PE2002000815 A PE 2002000815A PE 2002000815 A PE2002000815 A PE 2002000815A PE 20030340 A1 PE20030340 A1 PE 20030340A1
- Authority
- PE
- Peru
- Prior art keywords
- antihuman
- treatment
- antihumanetic
- hfe7a
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001257436 | 2001-08-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030340A1 true PE20030340A1 (es) | 2003-04-05 |
Family
ID=19085098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002000815A PE20030340A1 (es) | 2001-08-28 | 2002-08-26 | Metodo para el tratamiento o prevencion de desgaste oseo |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1421118A1 (fr) |
AR (1) | AR036305A1 (fr) |
CA (1) | CA2458993A1 (fr) |
PA (1) | PA8553901A1 (fr) |
PE (1) | PE20030340A1 (fr) |
WO (1) | WO2003020768A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003242265A1 (en) * | 2002-06-07 | 2003-12-22 | Sankyo Company, Limited | Combined effects of therapeutic or preventive agent composition for bone breakage |
US20050032807A1 (en) * | 2003-08-06 | 2005-02-10 | Rosenwald Lindsay A. | Methods of treating inflammatory diseases with ammonium salts of ornitihine derivatives |
EP2322220B1 (fr) * | 2008-08-01 | 2014-01-01 | Axis, Inc. | Agent thérapeutique ou agent préventif pour l'arthrose |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL352159A1 (en) * | 1999-05-24 | 2003-07-28 | Sankyo Co | Pharmaceutical compositions containing antibody against the fas |
-
2002
- 2002-08-26 PE PE2002000815A patent/PE20030340A1/es not_active Application Discontinuation
- 2002-08-27 WO PCT/JP2002/008630 patent/WO2003020768A1/fr not_active Application Discontinuation
- 2002-08-27 AR ARP020103216A patent/AR036305A1/es not_active Application Discontinuation
- 2002-08-27 CA CA002458993A patent/CA2458993A1/fr not_active Abandoned
- 2002-08-27 EP EP02762875A patent/EP1421118A1/fr not_active Withdrawn
- 2002-08-28 PA PA20028553901A patent/PA8553901A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2458993A1 (fr) | 2003-03-13 |
WO2003020768A1 (fr) | 2003-03-13 |
AR036305A1 (es) | 2004-08-25 |
PA8553901A1 (es) | 2003-06-30 |
EP1421118A1 (fr) | 2004-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP044978A (es) | ANTICUERPOS HUMANOS ANTAGONISTAS CONTRA hTNFSF13b | |
MX2023007748A (es) | Sintesis mejorada del intermedio clave del compuesto inhibidor de g12c de kras. | |
PE20120429A1 (es) | Proteinas de enlace de miostatina | |
NL301089I2 (nl) | imlifidase | |
ATE428731T1 (de) | Therapeutische antiköper mit reduzierten nebenwirkungen | |
CR9975A (es) | Anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de calcitonina | |
NO20044038L (no) | Glutaminylbaserte DRIV-inhibitorer | |
HN2011001210A (es) | Anticuerpos humanos de alta afinidad para el receptor il-4 humano | |
CY1109662T1 (el) | Ενωσεις πυρρολοτριαζινης ως αναστολεις κινασης | |
RS54468B1 (en) | MONOCLONAL ANTIBODIES AGAINST CLAUDINE-18 FOR THE CANCER TREATMENT | |
AR041374A1 (es) | Derivados de 2-oxodihidropiridina n- sustituidos | |
EA200401160A1 (ru) | Производные тиазола и оксазола, которые модулируют активность ppar | |
BRPI0314814B8 (pt) | anticorpo compreendendo uma variante de fc | |
PE20141162A1 (es) | Anticuerpos anti-il-23 | |
NO20030896D0 (no) | Nye dipeptidyl-peptidase IV-inhibitorer og deres anvendelse som anti-kreftmidler | |
PA8610601A1 (es) | Compuestos de bencimidazolona que tienen actividad agonista del receptor 5-ht4 | |
DK1937721T3 (da) | Anti-IL-23 antistoffer | |
TW200741134A (en) | Optical device for creating an illumination window | |
PE20220708A1 (es) | Anticuerpos anti-cd73 | |
SG10201807877TA (en) | Hybrid immunoglobulin containing non-peptidyl linkage | |
PE20130207A1 (es) | Anticuerpos antagonistas de lrp6 (proteina relacionada con lipoproteinas de baja densidad 6) y composiciones | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
CL2004000868A1 (es) | Compuestos derivados de acidos carboxilicos, antagonistas del receptor de calcio 8casr); composiciones farmaceuticas que comprenden el compuesto, utiles para el tratamiento de osteoporosis. | |
BR9908928A (pt) | Catalisadores de complexos de cianetos metálicos duplos modificados com compostos de cálcio | |
PH12021550244A1 (en) | Anti-btla antibody |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |